Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Online First

May 17, 2022

Systemic lupus erythematosus
Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials

Ian N Bruce, Richard A Furie, Eric F Morand, Susan Manzi, Yoshiya Tanaka, Kenneth C. Kalunian, Joan T Merrill, Patricia Puzio, Emmanuelle Maho, Christi Kleoudis, Marius Albulescu, Micki Hultquist, Raj Tummala

doi: 10.1136/annrheumdis-2021-221847

May 16, 2022

Systemic lupus erythematosus
Rising incidence and prevalence of systemic lupus erythematosus: a population-based study over four decades

Alí Duarte-García, Mehmet Hocaoglu, Maria Valenzuela-Almada, Shirley-Ann Osei-Onomah, Jesse Y Dabit, Alain Sanchez-Rodriguez, Stephanie Q Duong, Rachel E Giblon, Hannah E Langenfeld, Graciela S Alarcón, Charles G Helmick, Cynthia S Crowson

doi: 10.1136/annrheumdis-2022-222276

May 12, 2022

Letter
SGLT2 inhibitors in lupus nephropathy, a new therapeutic strategy for nephroprotection

Enrique Morales, Maria Galindo

doi: 10.1136/annrheumdis-2022-222512
Recommendation
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases
Free

Charlotte LM Krieckaert, Astrid van Tubergen, Johanna Elin Gehin, Borja Hernández-Breijo, Guillaume Le Mélédo, Alejandro Balsa, Peter Böhm, Sasa Cucnik, Ori Elkayam, Guro L Goll, Femke Hooijberg, Meghna Jani, Patrick DW Kiely, Neil McCarthy, Denis Mulleman, Victoria Navarro-Compán, Katherine Payne, Martin E Perry, Chamaida Plasencia-Rodriguez, Simon R Stones, Silje Watterdal Syversen, Annick de Vries, Katherine M Ward, Gertjan Wolbink, John D Isaacs

doi: 10.1136/annrheumdis-2022-222155

May 09, 2022

Osteoarthritis
Krüppel-like factor-4 and Krüppel-like factor-2 are important regulators of joint tissue cells and protect against tissue destruction and inflammation in osteoarthritis

Manabu Kawata, Takeshi Teramura, Philip Ordoukhanian, Steven R Head, Padmaja Natarajan, Aishwarya Sundaresan, Merissa Olmer, Hiroshi Asahara, Martin K Lotz

doi: 10.1136/annrheumdis-2021-221867

May 05, 2022

Letter
Sequential interleukin-17/interleukin-23 inhibition in treatment-refractory psoriatic arthritis

David Simon, Filippo Fagni, Georg Schett

doi: 10.1136/annrheumdis-2022-222415

April 29, 2022

Letter
Progressive increase in time to referral and persistently severe clinical presentation over the years in autoantibody-negative patients with rheumatoid arthritis in the setting of an early arthritis clinic

Ludovico De Stefano, Bernardo D’Onofrio, Garifallia Sakellariou, Antonio Manzo, Carlomaurizio Montecucco, Serena Bugatti

doi: 10.1136/annrheumdis-2022-222264
Correspondence response
Response to: Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’ by Braun and Landewé
Free

Robert BM Landewé, Juergen Braun

doi: 10.1136/annrheumdis-2022-222359
Correspondence
Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’ by Braun and Landewé
Free

Dafna D Gladman, Philip J Mease, Paul Bird, Enrique R Soriano, Soumya D Chakravarty, May Shawi, Frederic Lavie, Cinty Gong, Evan Leibowitz, Denis Poddubnyy, Lai-Shan Tam, Philip S Helliwell, Arthur Kavanaugh, Atul A Deodhar, Mikkel Østergaard, Xenofon Baraliakos

doi: 10.1136/annrheumdis-2022-222161

April 27, 2022

Systemic lupus erythematosus
Biological impact of iberdomide in patients with active systemic lupus erythematosus

Peter E Lipsky, Ronald van Vollenhoven, Thomas Dörner, Victoria P Werth, Joan T Merrill, Richard Furie, Milan Petronijevic, Benito Velasco Zamora, Maria Majdan, Fedra Irazoque-Palazuelos, Robert Terbrueggen, Nikolay Delev, Michael Weiswasser, Shimon Korish, Mark Stern, Sarah Hersey, Ying Ye, Allison Gaudy, Zhaohui Liu, Robert Gagnon, Shaojun Tang, Peter H Schafer

doi: 10.1136/annrheumdis-2022-222212
Heroes and pillars of rheumatology
Eleonora Reicher: a pioneer of European rheumatology

Eugene J Kucharz

doi: 10.1136/annrheumdis-2022-222567

April 25, 2022

Systemic lupus erythematosus
Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart function

Sabrina Meisgen, Malin Hedlund, Aurelie Ambrosi, Lasse Folkersen, Vijole Ottosson, David Forsberg, Gudny Ella Thorlacius, Luca Biavati, Linn Strandberg, Johannes Mofors, Daniel Ramskold, Sabrina Ruhrmann, Lauro Meneghel, William Nyberg, Alexander Espinosa, Robert Murray Hamilton, Anders Franco-Cereceda, Anders Hamsten, Tomas Olsson, Lois Greene, Per Eriksson, Kristina Gemzell-Danielsson, Stina Salomonsson, Vijay K Kuchroo, Eric Herlenius, Ingrid Kockum, Sven-Erik Sonesson, Marie Wahren-Herlenius

doi: 10.1136/annrheumdis-2021-221714
Review
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis

Lotte van Ouwerkerk, Andriko Palmowski, Isabell S Nevins, Frank Buttgereit, Patrick Verschueren, Josef S Smolen, Robert BM Landewé, Johannes JW Bijlsma, Andreas Kerschbaumer, René Westhovens, Tom WJ Huizinga, Cornelia F Allaart, Sytske Anne Bergstra

doi: 10.1136/annrheumdis-2022-222338
Epidemiology
2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases
Free

Annette de Thurah, Philipp Bosch, Andrea Marques, Yvette Meissner, Chetan B Mukhtyar, Johannes Knitza, Aurélie Najm, Nina Østerås, Tim Pelle, Line Raunsbæk Knudsen, Hana Šmucrová, Francis Berenbaum, Meghna Jani, Rinie Geenen, Martin Krusche, Polina Pchelnikova, Savia de Souza, Sara Badreh, Dieter Wiek, Silvia Piantoni, James M Gwinnutt, Christina Duftner, Helena M Canhão, Luca Quartuccio, Nikolay Stoilov, Yeliz Prior, Johannes WJ Bijlsma, Alen Zabotti, Tanja A Stamm, Christian Dejaco

doi: 10.1136/annrheumdis-2022-222341
Rheumatoid arthritis
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset

Saedis Saevarsdottir, Lilja Stefansdottir, Patrick Sulem, Gudmar Thorleifsson, Egil Ferkingstad, Gudrun Rutsdottir, Bente Glintborg, Helga Westerlind, Gerdur Grondal, Isabella C Loft, Signe Bek Sorensen, Benedicte A Lie, Mikael Brink, Lisbeth Ärlestig, Asgeir Orn Arnthorsson, Eva Baecklund, Karina Banasik, Steffen Bank, Lena I Bjorkman, Torkell Ellingsen, Christian Erikstrup, Oleksandr Frei, Inger Gjertsson, Daniel F Gudbjartsson, Sigurjon A Gudjonsson, Gisli H Halldorsson, Oliver Hendricks, Jan Hillert, Estrid Hogdall, Søren Jacobsen, Dorte Vendelbo Jensen, Helgi Jonsson, Alf Kastbom, Ingrid Kockum, Salome Kristensen, Helga Kristjansdottir, Margit H Larsen, Asta Linauskas, Ellen-Margrethe Hauge, Anne G Loft, Bjorn R Ludviksson, Sigrun H Lund, Thorsteinn Markusson, Gisli Masson, Pall Melsted, Kristjan H S Moore, Heidi Munk, Kaspar R Nielsen, Gudmundur L Norddahl, Asmundur Oddsson, Thorunn A Olafsdottir, Pall I Olason, Tomas Olsson, Sisse Rye Ostrowski, Kim Hørslev-Petersen, Solvi Rognvaldsson, Helga Sanner, Gilad N Silberberg, Hreinn Stefansson, Erik Sørensen, Inge J Sørensen, Carl Turesson, Thomas Bergman, Lars Alfredsson, Tore K Kvien, Søren Brunak, Kristján Steinsson, Vibeke Andersen, Ole A Andreassen, Solbritt Rantapää-Dahlqvist, Merete Lund Hetland, Lars Klareskog, Johan Askling, Leonid Padyukov, Ole BV Pedersen, Unnur Thorsteinsdottir, Ingileif Jonsdottir, Kari Stefansson, Members of the DBDS Genomic Consortium, The Danish RA Genetics Working Group The Swedish Rheumatology Quality Register Biobank Study Group (SRQb)

doi: 10.1136/annrheumdis-2021-221754

April 22, 2022

Rheumatoid arthritis
Isolation of HLA-DR-naturally presented peptides identifies T-cell epitopes for rheumatoid arthritis

Jaxaira Maggi, Montserrat Carrascal, Lilian Soto, Oscar Neira, María C Cuéllar, Octavio Aravena, Eddie A James, Joaquin Abian, Dolores Jaraquemada, Diego Catalan, Juan C Aguillón

doi: 10.1136/annrheumdis-2021-220371
Letter
Cross-reactivity of anti-modified protein antibodies is also present in predisease and individuals without rheumatoid arthritis

Sanne Reijm, Astrid S Brehler, Solbritt Rantapää-Dahlqvist, Atsushi Kawakami, Takahiro Maeda, Shin-ya Kawashiri, Mami Tamai, Diane van der Woude, René E M Toes

doi: 10.1136/annrheumdis-2022-222326
Psoriatic arthritis
Concise report: a minimal-invasive method to retrieve and identify entheseal tissue from psoriatic arthritis patients

Milena L Pachowsky, Maria Gabriella Raimondo, Cong Xu, Simon Rauber, Koray Tascilar, Hannah Labinsky, Mario Vogg, Mina Saad Aziz Saad, David Simon, Juergen Rech, Alina Soare, Lars Braeuer, Arnd Kleyer, Georg Schett, Andreas Ramming

doi: 10.1136/annrheumdis-2021-222061
Epidemiology
BNT162b2 mRNA COVID-19 vaccine and booster in patients with autoimmune rheumatic diseases: a national cohort study
Free

Amir Bieber, Iftach Sagy, Lena Novack, Shay Brikman, Ran Abuhasira, Snait Ayalon, Irina Novofastovski, Mahmoud Abu-Shakra, Reuven Mader

doi: 10.1136/annrheumdis-2021-221824
Rheumatoid arthritis
Deletion of activin A in mesenchymal but not myeloid cells ameliorates disease severity in experimental arthritis

Vanessa Waltereit-Kracke, Corinna Wehmeyer, Denise Beckmann, Eugenie Werbenko, Julia Reinhardt, Fabienne Geers, Mike Dienstbier, Michelle Fennen, Johanna Intemann, Peter Paruzel, Adelheid Korb-Pap, Thomas Pap, Berno Dankbar

doi: 10.1136/annrheumdis-2021-221409

April 15, 2022

Autoinflammatory disorders
Low-ratio somatic NLRC4 mutation causes late-onset autoinflammatory disease

Jun Wang, Qiao Ye, Wenjie Zheng, Xiaomin Yu, Fang Luo, Ran Fang, Yaoyao Shangguan, Zhijun Du, Pui Y Lee, Taijie Jin, Qing Zhou

doi: 10.1136/annrheumdis-2021-221708

April 13, 2022

Letter
Humoral immune-response to a SARS-CoV-2-BNT162b2 booster in inflammatory arthritis patients who received an inactivated virus vaccine

Josefina Durán, Paula Isabel Burgos, Nicole Le Corre, Cinthya Ruiz Tagle, Constanza Martinez-Valdebenito, Mauricio Castro, Valentina Metcalfe, Paula Niemann, M Elvira Balcells

doi: 10.1136/annrheumdis-2022-222189
Vasculitis
CSF2-dependent monocyte education in the pathogenesis of ANCA-induced glomerulonephritis

Anthony Rousselle, Janis Sonnemann, Kerstin Amann, Alexander Mildner, Dörte Lodka, Lovis Kling, Markus Bieringer, Udo Schneider, Achim Leutz, Philipp Enghard, Ralph Kettritz, Adrian Schreiber

doi: 10.1136/annrheumdis-2021-221984

April 12, 2022

Autoimmunity
Tfh cells with NLRP3 inflammasome activation are essential for high-affinity antibody generation, germinal centre formation and autoimmunity

Zhenhuan Zhao, Bihua Xu, Shuang Wang, Mianjing Zhou, Yuefang Huang, Chaohuan Guo, Mengyuan Li, Jijun Zhao, Sun-Sang J Sung, Felicia Gaskin, Niansheng Yang, Shu Man Fu

doi: 10.1136/annrheumdis-2021-221985

April 08, 2022

Letter
Severely impaired humoral response against SARS-CoV-2 variants of concern following two doses of BNT162b2 vaccine in patients with systemic lupus erythematosus (SLE)

Arthur Mageau, Valentine Marie Ferré, Tiphaine Goulenok, Charlotte Charpentier, Nicole Delory, Chrystel Francois, Nadhira Houhou-Fidouh, Thomas Papo, Diane Descamps, Karim Sacre

doi: 10.1136/annrheumdis-2022-222498

April 07, 2022

Sjögren’s syndrome
Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome

Raphaele Seror, Gabriel Baron, Marine Camus, Divi Cornec, Elodie Perrodeau, Simon J Bowman, Michele Bombardieri, Hendrika Bootsma, Jacques-Eric Gottenberg, Benjamin Fisher, Wolfgang Hueber, Joel A van Roon, Valérie Devauchelle-Pensec, Peter Gergely, Xavier Mariette, Raphael Porcher on behalf of the NECESSITY WP5 - STAR development working group

doi: 10.1136/annrheumdis-2021-222054
Psoriatic arthritis
Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure

Atul A Deodhar, Bernard Combe, Ana P Accioly, Rebecca Bolce, Danting Zhu, Amanda M Gellett, Aubrey Trevelin Sprabery, Gerd-Rüdiger R Burmester

doi: 10.1136/annrheumdis-2021-222027

March 25, 2022

Systemic lupus erythematosus
Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

May Yee Choi, Ann Elaine Clarke, Murray Urowitz, John Hanly, Yvan St-Pierre, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Daniel J Wallace, David Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcón, Ronald F van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sam Lim, Murat Inanc, Ken Kalunian, Søren Jacobsen, Christine Peschken, Diane L Kamen, Anca Askanase, Jill P Buyon, Karen H Costenbader, Marvin J Fritzler

doi: 10.1136/annrheumdis-2022-222168
Letter
Pilot study of baricitinib for active Sjogren’s syndrome

Wei Bai, Huilan Liu, Lei Dou, YunJiao Yang, XiaoMei Leng, Mengtao Li, Wen Zhang, Yan Zhao, Xiaofeng Zeng

doi: 10.1136/annrheumdis-2021-222053
Paediatric rheumatology
Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases
Free

Lianne Kearsley-Fleet, Min-Lee Chang, Saskia Lawson-Tovey, Ruth Costello, Šárka Fingerhutová, Natálie Švestková, Alexandre Belot, Florence A Aeschlimann, Isabelle Melki, Isabelle Koné-Paut, Sascha Eulert, Tilmann Kallinich, Yackov Berkun, Yosef Uziel, Bernd Raffeiner, Filipa Oliveira Ramos, Daniel Clemente, Christina Dackhammar, Nico M Wulffraat, Helen Waite, Anja Strangfeld, Elsa F Mateus, Pedro M Machado, CARRA Registry Investigators, COVID-19 Global Pediatric Rheumatology Database Investigators, Marc Natter, Kimme L Hyrich

doi: 10.1136/annrheumdis-2022-222241
Systemic lupus erythematosus
Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials

Edward M Vital, Joan T Merrill, Eric F Morand, Richard A Furie, Ian N Bruce, Yoshiya Tanaka, Susan Manzi, Kenneth C Kalunian, Rubana N Kalyani, Katie Streicher, Gabriel Abreu, Raj Tummala

doi: 10.1136/annrheumdis-2021-221425

March 22, 2022

Correspondence
Correspondence on ‘2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis’ by Joanna C Robson et al and ‘2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis’ by Ravi Suppiah et al
Free

Victor Román Pimentel-Quiroz, Manuel Francisco Ugarte-Gil, Graciela S Alarcón

doi: 10.1136/annrheumdis-2022-222317
Correspondence response
Response to: Correspondence on ‘2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis’ by Joanna C Robson et al and ‘2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis’ by Ravi Suppiah et al
Free

Peter C Grayson, Joanna C Robson, Ravi Suppiah, Cristina Ponte, Richard A Watts, Raashid A Luqmani, Peter A Merkel

doi: 10.1136/annrheumdis-2022-222362

March 18, 2022

Letter
Comparison of ultrasound attenuation by calcium pyrophosphate, hydroxyapatite and monosodium urate crystals: a proof-of-concept study

Georgios Filippou, Giovanni Pacini, Silvia Sirotti, Matthias Zadory, Davide Carboni, Arianna Damiani, Elisa Fiorentini, Edoardo Cipolletta, Emilio Filippucci, Johannes M Froehlich, Piercarlo Sarzi Puttini, Fabio Becce

doi: 10.1136/annrheumdis-2022-222316
Epidemiology
Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort study
Free

Peter Mandl, Selma Tobudic, Helmut Haslacher, Thomas Karonitsch, Daniel Mrak, Thomas Nothnagl, Thomas Perkmann, Helga Radner, Judith Sautner, Elisabeth Simader, Florian Winkler, Heinz Burgmann, Daniel Aletaha, Stefan Winkler, Stephan Blüml

doi: 10.1136/annrheumdis-2021-221788

March 14, 2022

Letter
Eosinopenia to differentiate crystal-induced and septic arthritis

Agathe Vigouroux, Agnes Ostertag, Anne-Claude Crémieux, Thomas Bardin, Augustin Latourte, Hang-Korng Ea, Pascal Richette

doi: 10.1136/annrheumdis-2022-222322

March 11, 2022

Crystal arthropathies
Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination

Jie Lu, Yuwei He, Robert Terkeltaub, Mingshu Sun, Zijing Ran, Xinmiao Xu, Can Wang, Xinde Li, Shuhui Hu, Xiaomei Xue, Fei Yan, Hui Zhang, Huiyong Yin, Yongyong Shi, Nicola Dalbeth, Changgui Li

doi: 10.1136/annrheumdis-2022-222199
Autoimmunity
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases
Free

Nádia Emi Aikawa, Leonard de Vinci Kanda Kupa, Ana Cristina Medeiros-Ribeiro, Carla Goncalves Schahin Saad, Emily Figueiredo Neves Yuki, Sandra Gofinet Pasoto, Priscila Tagliaferro Rojo, Rosa Maria Rodrigues Pereira, Samuel Katsuyuki Shinjo, Percival Degrava Sampaio-Barros, Danieli Castro Oliveira Andrade, Ari Stiel Radu Halpern, Ricardo Fuller, Fernando Henrique Carlos Souza, Lissiane Karine Noronha Guedes, Ana Paula Luppino Assad, Julio Cesar Bertacini de Moraes, Michelle Remiao Ugolini Lopes, Victor Adriano de Oliveira Martins, Lorena Betancourt, Carolina Torres Ribeiro, Lucas Peixoto Sales, Isabela Maria Bertoglio, Virginia Lucia Nazario Bonoldi, Renata Lys Pinheiro Mello, Gustavo Guimaraes Moreira Balbi, Ana Marli Christovam Sartori, Leila Antonangelo, Clóvis Artur Silva, Eloisa Bonfa

doi: 10.1136/annrheumdis-2021-222096

March 08, 2022

Paediatric rheumatology
Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial

Joachim Gerss, Monika Tedy, Ariane Klein, Gerd Horneff, Maria Miranda-Garcia, Christoph Kessel, Dirk Holzinger, Valda Stanevica, Joost F Swart, David A Cabral, Hermine I Brunner, Dirk Foell

doi: 10.1136/annrheumdis-2021-222029
Recommendation
2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases
Free

James M Gwinnutt, Maud Wieczorek, Andra Balanescu, Heike A Bischoff-Ferrari, Annelies Boonen, Giulio Cavalli, Savia de Souza, Annette de Thurah, Thomas E Dorner, Rikke Helene Moe, Polina Putrik, Javier Rodríguez-Carrio, Lucía Silva-Fernández, Tanja Stamm, Karen Walker-Bone, Joep Welling, Mirjana I Zlatković-Švenda, Francis Guillemin, Suzanne M M Verstappen

doi: 10.1136/annrheumdis-2021-222020

March 03, 2022

Recommendation
EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology
Free

Aurélie Najm, Félicie Costantino, Stefano Alivernini, Alessia Alunno, Elettra Bianchi, Jacqueline Bignall, Brendan Boyce, Juan D Cañete, Francesco Carubbi, Patrick Durez, João Eurico Fonseca, Søren Andreas Just, Raquel Largo, Antonio Manzo, Mark Maybury, Esperanza Naredo, Carl Orr, Costantino Pitzalis, Felice Rivellese, Vasco C Romão, Jef van Rompay, Sander W Tas, Douglas J Veale, Maria-Antonietta D'Agostino, Andrew Filer

doi: 10.1136/annrheumdis-2021-221875

March 02, 2022

Letter
No excess mortality in contemporary undifferentiated arthritis, in contrast to rheumatoid arthritis: a study with a follow-up of at least 10 years

Marloes Verstappen, Tom WJ Huizinga, Annette HM van der Helm-van Mil

doi: 10.1136/annrheumdis-2022-222145

February 25, 2022

Letter
Comparative analysis of SGLT-2 expression in renal vasculitis and lupus nephritis

Samy Hakroush, Desiree Tampe, Ingmar Alexander Kluge, Eva Baier, Peter Korsten, Björn Tampe

doi: 10.1136/annrheumdis-2022-222167

February 23, 2022

Recommendation
EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update
Free

Robert B M Landewé, Féline P B Kroon, Alessia Alunno, Aurélie Najm, Johannes WJ Bijlsma, Gerd-Rüdiger R Burmester, Roberto Caporali, Bernard Combe, Richard Conway, Jeffrey R Curtis, Ori Elkayam, Laure Gossec, Marloes W Heijstek, Lukas Haupt, Annamaria Iagnocco, John D Isaacs, István Ábel Juhász, Suzi Makri, Xavier Mariette, Iain B McInnes, Puja Mehta, Ulf Mueller-Ladner, Hendrik Schulze-Koops, Josef S Smolen, Dieter Wiek, Kevin L Winthrop, Victoria Navarro-Compán, Pedro M Machado

doi: 10.1136/annrheumdis-2021-222006

February 17, 2022

Correspondence
Correspondence on ‘Re-examining remission definitions in rheumatoid arthritis: considering the 28-joint Disease Activity Score, C reactive protein level and patient global assessment’ by Felson et al
Free

Ricardo J O Ferreira, Paco M J Welsing, Johannes WG Jacobs, Laure Gossec, Mwidimi Ndosi, Pedro M Machado, Désirée van der Heijde, Jose AP Da Silva

doi: 10.1136/annrheumdis-2021-221917
Correspondence response
Response to: Correspondence on ‘Re-examining remission definitions in rheumatoid arthritis: considering the 28-Joint Disease Activity Score, C-reactive protein level and patient global assessment’ by Felson et al
Free

David Felson, Diane Lacaille, Michael P LaValley, Daniel Aletaha

doi: 10.1136/annrheumdis-2021-221941

February 16, 2022

Systemic lupus erythematosus
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance
Free

Manuel Francisco Ugarte-Gil, Graciela S Alarcón, Zara Izadi, Ali Duarte-García, Cristina Reátegui-Sokolova, Ann Elaine Clarke, Leanna Wise, Guillermo J Pons-Estel, Maria Jose Santos, Sasha Bernatsky, Sandra Lúcia Euzébio Ribeiro, Samar Al Emadi, Jeffrey A Sparks, Tiffany Y -T Hsu, Naomi J Patel, Emily L Gilbert, Maria O Valenzuela-Almada, Andreas Jönsen, Gianpiero Landolfi, Micaela Fredi, Tiphaine Goulenok, Mathilde Devaux, Xavier Mariette, Viviane Queyrel, Vasco C Romão, Graca Sequeira, Rebecca Hasseli, Bimba Hoyer, Reinhard E Voll, Christof Specker, Roberto Baez, Vanessa Castro-Coello, Hernan Maldonado Ficco, Edgard Torres Reis Neto, Gilda Aparecida Aparecida Ferreira, Odirlei Andre André Monticielo, Emily Sirotich, Jean Liew, Jonathan Hausmann, Paul Sufka, Rebecca Grainger, Suleman Bhana, Wendy Costello, Zachary S Wallace, Lindsay Jacobsohn, Tiffany Taylor, Clairissa Ja, Anja Strangfeld, Elsa F Mateus, Kimme L Hyrich, Loreto Carmona, Saskia Lawson-Tovey, Lianne Kearsley-Fleet, Martin Schäfer, Pedro M Machado, Philip C Robinson, Milena Gianfrancesco, Jinoos Yazdany

doi: 10.1136/annrheumdis-2021-221636

February 15, 2022

Letter
Rheumatoid arthritis disease activity assessed by patient-reported outcomes and flow cytometry before and after an additional dose of COVID-19 vaccine
Free

Sara K Tedeschi, Jacklyn Stratton, Jack Elias Ellrodt, Mary Grace Whelan, Keigo Hayashi, Kazuki Yoshida, Lin Chen, Ifeoluwakiisi Adejoorin, Kathryne Elizabeth Marks, A. Helena Jonsson, Deepak A Rao, Daniel H Solomon

doi: 10.1136/annrheumdis-2022-222232
Letter
Management of rheumatoid arthritis in China: a study of the implementation of 2019 EULAR recommendations

Shangyi Jin, Nan Jiang, Yuehong Huo, Xinwang Duan, Yongfei Fang, Cheng Zhao, Hongbin Li, Min Yang, Zhirao Huang, Pingting Yang, Hongfeng Zhang, Feng Zhan, Youlian Wang, Yanhong Wang, Chanyuan Wu, Qian Wang, Evelyn Hsieh, Mengtao Li, Xinping Tian, Yan Zhao, Xiaofeng Zeng

doi: 10.1136/annrheumdis-2021-221841

February 10, 2022

Letter
Neutralisation of circulating SARS-CoV-2 delta and omicron variants by convalescent plasma and SARS-CoV-2 hyperimmune intravenous human immunoglobulins for treatment of COVID-19
Free

Fatema Tuz Zahra, Lorenza Bellusci, Gabrielle Grubbs, Hana Golding, Surender Khurana

doi: 10.1136/annrheumdis-2022-222115

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

May 17, 2022

May 16, 2022

May 12, 2022

May 09, 2022

May 05, 2022

April 29, 2022

April 27, 2022

April 25, 2022

April 22, 2022

April 15, 2022

April 13, 2022

April 12, 2022

April 08, 2022

April 07, 2022

March 25, 2022

March 22, 2022

March 18, 2022

March 14, 2022

March 11, 2022

March 08, 2022

March 03, 2022

March 02, 2022

February 25, 2022

February 23, 2022

February 17, 2022

February 16, 2022

February 15, 2022

February 10, 2022

Pages